BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Demirli Atici S, Kamer E. Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? World J Gastroenterol 2022; 28(4): 500-501 [PMID: 35125833 DOI: 10.3748/wjg.v28.i4.500]
URL: https://www.wjgnet.com/1007-9327/full/v28/i4/500.htm
Number Citing Articles
1
Chen Shen, Wen Gu, Xiaojun Zhou. WITHDRAWN: Characterization of mutational landscape reveals influencing factors for therapeutic response and prognosis of colorectal cancer patients with synchronous liver metastases underwent simultaneous resection of primary and metastatic lesionsSurgery Open Science 2024;  doi: 10.1016/j.sopen.2023.12.004
2
Yun-Jie Hao, Lu-Wey Chang, Chih-Yung Yang, Liang-Chuan Lo, Chien-Ping Lin, Yuan-Wei Jian, Jeng-Kai Jiang, Fan-Gang Tseng. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatmentTranslational Research 2024; 263: 1 doi: 10.1016/j.trsl.2023.07.011